NTRK3 and acute lymphoblastic leukemia: Roberts et al. showed in their mouse model that ETV6-NTRK3-positive cells exposed upregulation of genes of the activator protein (AP-)1 pathway [62], which may represent one reason for the CNS infiltrating capacity of NTRK3 fusion positive ALL.